Karin Hedenmalm
Clinical Trial Unit
Medical Products Agency
Box 26
751 03
Sweden
Name/email consistency: high
- Muscle toxicity with statins. Hedenmalm, K., Alvan, G., Ohagen, P., Dahl, M.L. Pharmacoepidemiol. Drug. Saf (2010)
- The conscientious judgement of a DSMB--statistical stopping rules re-examined. Hedenmalm, K., Melander, H., Alvan, G. Eur. J. Clin. Pharmacol. (2008)
- Risk factors for extrapyramidal symptoms during treatment with selective serotonin reuptake inhibitors, including cytochrome P-450 enzyme, and serotonin and dopamine transporter and receptor polymorphisms. Hedenmalm, K., Güzey, C., Dahl, M.L., Yue, Q.Y., Spigset, O. J. Clin. Psychopharmacol (2006)
- Alopecia associated with treatment with selective serotonin reuptake inhibitors (SSRIs). Hedenmalm, K., Sundström, A., Spigset, O. Pharmacoepidemiol. Drug. Saf (2006)
- Fatal venous thromboembolism associated with different combined oral contraceptives: a study of incidences and potential biases in spontaneous reporting. Hedenmalm, K., Samuelsson, E. Drug. Saf (2005)
- Pulmonary embolism associated with combined oral contraceptives: reporting incidences and potential risk factors for a fatal outcome. Hedenmalm, K., Samuelsson, E., Spigset, O. Acta. Obstet. Gynecol. Scand (2004)
- Increased liability of tramadol-warfarin interaction in individuals with mutations in the cytochrome P450 2D6 gene. Hedenmalm, K., Lindh, J.D., Säwe, J., Rane, A. Eur. J. Clin. Pharmacol. (2004)
- Agranulocytosis and other blood dyscrasias associated with dipyrone (metamizole). Hedenmalm, K., Spigset, O. Eur. J. Clin. Pharmacol. (2002)
- Glucose intolerance with atypical antipsychotics. Hedenmalm, K., Hägg, S., Ståhl, M., Mortimer, O., Spigset, O. Drug. Saf (2002)